StockNow
Log in
Global Markets

Dr Reddy's (DRRD IS) exec says if pharma tariffs are imposed, will raise prices in the US

StockNow breaking-news AI analysis

Dr Reddy's plans to offset aggressive US generic tariffs (100-200% by 2028-2029) with price hikes, amid declining North American revenues and concurrent semaglutide supply disruptions.

1 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Eli Lilly (LLY) Q2 2026 (USD): Adj. EPS 8.38 (exp. 6.01), Revenue 23bln (exp. 20.7bln)

LLYGeopolitics

Pakistani sources say Pakistan PM Sharif and Army Chief Munir will visit Saudi Arabia tomorrow, Al Hadath reports

U.S. Economy

US ADP Employment Change (Jul) 44K vs. Exp. 70K (Prev. 98K)